Diane E. Wilfong - Mar 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Signature
/s/ Amy Kim by Power of Attorney for Diane E. Wilfong
Stock symbol
GILD
Transactions as of
Mar 10, 2022
Transactions value $
-$54,155
Form type
4
Date filed
3/14/2022, 09:30 PM
Previous filing
Feb 8, 2022
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $0 +2.03K +8.36% $0.00 26.2K Mar 10, 2022 Direct F1
transaction GILD Common Stock Options Exercise $0 +1.27K +4.85% $0.00 27.5K Mar 10, 2022 Direct F1
transaction GILD Common Stock Tax liability -$54.2K -935 -3.4% $57.92 26.6K Mar 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2.03K -14.42% 12K Mar 10, 2022 Common Stock 2.03K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -1.27K -10.58% 10.7K Mar 10, 2022 Common Stock 1.27K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +18.9K $0.00 18.9K Mar 10, 2022 Common Stock 18.9K $57.92 Direct F4
transaction GILD Restricted Stock Unit Award +5.61K +52.21% 16.4K Mar 10, 2022 Common Stock 5.61K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.